The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Immuno Oncology Assays Market Research Report 2025

Global Immuno Oncology Assays Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1936175

No of Pages : 67

Ask Your Query

Synopsis

Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).

The global Immuno Oncology Assays market was valued at US$ 4439.4 million in 2023 and is anticipated to reach US$ 9297.8 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.

North American market for Immuno Oncology Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Immuno Oncology Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Immuno Oncology Assays in Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Immuno Oncology Assays include Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies and Illumina, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Immuno Oncology Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno Oncology Assays.

Report Scope

The Immuno Oncology Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immuno Oncology Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immuno Oncology Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Thermo Fischer Scientific
  • Roche Diagnostics
  • Agilent Technologies
  • Illumina

Segment by Type

  • Immunoassay
  • Flow Cytometry
  • PCR
  • Next Generation Sequencing

Segment by Application

  • Research
  • Clinical Diagnostics

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno Oncology Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno Oncology Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunoassay
1.2.3 Flow Cytometry
1.2.4 PCR
1.2.5 Next Generation Sequencing
1.3 Market by Application
1.3.1 Global Immuno Oncology Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research
1.3.3 Clinical Diagnostics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno Oncology Assays Market Perspective (2019-2030)
2.2 Immuno Oncology Assays Growth Trends by Region
2.2.1 Global Immuno Oncology Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immuno Oncology Assays Historic Market Size by Region (2019-2024)
2.2.3 Immuno Oncology Assays Forecasted Market Size by Region (2025-2030)
2.3 Immuno Oncology Assays Market Dynamics
2.3.1 Immuno Oncology Assays Industry Trends
2.3.2 Immuno Oncology Assays Market Drivers
2.3.3 Immuno Oncology Assays Market Challenges
2.3.4 Immuno Oncology Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno Oncology Assays Players by Revenue
3.1.1 Global Top Immuno Oncology Assays Players by Revenue (2019-2024)
3.1.2 Global Immuno Oncology Assays Revenue Market Share by Players (2019-2024)
3.2 Global Immuno Oncology Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno Oncology Assays Revenue
3.4 Global Immuno Oncology Assays Market Concentration Ratio
3.4.1 Global Immuno Oncology Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno Oncology Assays Revenue in 2023
3.5 Immuno Oncology Assays Key Players Head office and Area Served
3.6 Key Players Immuno Oncology Assays Product Solution and Service
3.7 Date of Enter into Immuno Oncology Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno Oncology Assays Breakdown Data by Type
4.1 Global Immuno Oncology Assays Historic Market Size by Type (2019-2024)
4.2 Global Immuno Oncology Assays Forecasted Market Size by Type (2025-2030)
5 Immuno Oncology Assays Breakdown Data by Application
5.1 Global Immuno Oncology Assays Historic Market Size by Application (2019-2024)
5.2 Global Immuno Oncology Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immuno Oncology Assays Market Size (2019-2030)
6.2 North America Immuno Oncology Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immuno Oncology Assays Market Size by Country (2019-2024)
6.4 North America Immuno Oncology Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno Oncology Assays Market Size (2019-2030)
7.2 Europe Immuno Oncology Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immuno Oncology Assays Market Size by Country (2019-2024)
7.4 Europe Immuno Oncology Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno Oncology Assays Market Size (2019-2030)
8.2 Asia-Pacific Immuno Oncology Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immuno Oncology Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Immuno Oncology Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno Oncology Assays Market Size (2019-2030)
9.2 Latin America Immuno Oncology Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immuno Oncology Assays Market Size by Country (2019-2024)
9.4 Latin America Immuno Oncology Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno Oncology Assays Market Size (2019-2030)
10.2 Middle East & Africa Immuno Oncology Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immuno Oncology Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Immuno Oncology Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fischer Scientific
11.1.1 Thermo Fischer Scientific Company Detail
11.1.2 Thermo Fischer Scientific Business Overview
11.1.3 Thermo Fischer Scientific Immuno Oncology Assays Introduction
11.1.4 Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2019-2024)
11.1.5 Thermo Fischer Scientific Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Detail
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Immuno Oncology Assays Introduction
11.2.4 Roche Diagnostics Revenue in Immuno Oncology Assays Business (2019-2024)
11.2.5 Roche Diagnostics Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Immuno Oncology Assays Introduction
11.3.4 Agilent Technologies Revenue in Immuno Oncology Assays Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Immuno Oncology Assays Introduction
11.4.4 Illumina Revenue in Immuno Oncology Assays Business (2019-2024)
11.4.5 Illumina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Immuno Oncology Assays Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunoassay
Table 3. Key Players of Flow Cytometry
Table 4. Key Players of PCR
Table 5. Key Players of Next Generation Sequencing
Table 6. Global Immuno Oncology Assays Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Immuno Oncology Assays Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Immuno Oncology Assays Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Immuno Oncology Assays Market Share by Region (2019-2024)
Table 10. Global Immuno Oncology Assays Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Immuno Oncology Assays Market Share by Region (2025-2030)
Table 12. Immuno Oncology Assays Market Trends
Table 13. Immuno Oncology Assays Market Drivers
Table 14. Immuno Oncology Assays Market Challenges
Table 15. Immuno Oncology Assays Market Restraints
Table 16. Global Immuno Oncology Assays Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Immuno Oncology Assays Market Share by Players (2019-2024)
Table 18. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2023)
Table 19. Ranking of Global Top Immuno Oncology Assays Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Immuno Oncology Assays Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immuno Oncology Assays Product Solution and Service
Table 23. Date of Enter into Immuno Oncology Assays Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immuno Oncology Assays Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Immuno Oncology Assays Revenue Market Share by Type (2019-2024)
Table 27. Global Immuno Oncology Assays Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Immuno Oncology Assays Revenue Market Share by Type (2025-2030)
Table 29. Global Immuno Oncology Assays Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Immuno Oncology Assays Revenue Market Share by Application (2019-2024)
Table 31. Global Immuno Oncology Assays Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Immuno Oncology Assays Revenue Market Share by Application (2025-2030)
Table 33. North America Immuno Oncology Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Immuno Oncology Assays Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Immuno Oncology Assays Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Immuno Oncology Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Immuno Oncology Assays Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Immuno Oncology Assays Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Immuno Oncology Assays Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Immuno Oncology Assays Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Immuno Oncology Assays Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Immuno Oncology Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Immuno Oncology Assays Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Immuno Oncology Assays Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Immuno Oncology Assays Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Immuno Oncology Assays Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Immuno Oncology Assays Market Size by Country (2025-2030) & (US$ Million)
Table 48. Thermo Fischer Scientific Company Detail
Table 49. Thermo Fischer Scientific Business Overview
Table 50. Thermo Fischer Scientific Immuno Oncology Assays Product
Table 51. Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2019-2024) & (US$ Million)
Table 52. Thermo Fischer Scientific Recent Development
Table 53. Roche Diagnostics Company Detail
Table 54. Roche Diagnostics Business Overview
Table 55. Roche Diagnostics Immuno Oncology Assays Product
Table 56. Roche Diagnostics Revenue in Immuno Oncology Assays Business (2019-2024) & (US$ Million)
Table 57. Roche Diagnostics Recent Development
Table 58. Agilent Technologies Company Detail
Table 59. Agilent Technologies Business Overview
Table 60. Agilent Technologies Immuno Oncology Assays Product
Table 61. Agilent Technologies Revenue in Immuno Oncology Assays Business (2019-2024) & (US$ Million)
Table 62. Agilent Technologies Recent Development
Table 63. Illumina Company Detail
Table 64. Illumina Business Overview
Table 65. Illumina Immuno Oncology Assays Product
Table 66. Illumina Revenue in Immuno Oncology Assays Business (2019-2024) & (US$ Million)
Table 67. Illumina Recent Development
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno Oncology Assays Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Immuno Oncology Assays Market Share by Type: 2023 VS 2030
Figure 3. Immunoassay Features
Figure 4. Flow Cytometry Features
Figure 5. PCR Features
Figure 6. Next Generation Sequencing Features
Figure 7. Global Immuno Oncology Assays Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Immuno Oncology Assays Market Share by Application: 2023 VS 2030
Figure 9. Research Case Studies
Figure 10. Clinical Diagnostics Case Studies
Figure 11. Immuno Oncology Assays Report Years Considered
Figure 12. Global Immuno Oncology Assays Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Immuno Oncology Assays Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Immuno Oncology Assays Market Share by Region: 2023 VS 2030
Figure 15. Global Immuno Oncology Assays Market Share by Players in 2023
Figure 16. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Immuno Oncology Assays Revenue in 2023
Figure 18. North America Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Immuno Oncology Assays Market Share by Country (2019-2030)
Figure 20. United States Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Immuno Oncology Assays Market Share by Country (2019-2030)
Figure 24. Germany Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Immuno Oncology Assays Market Share by Region (2019-2030)
Figure 32. China Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Immuno Oncology Assays Market Share by Country (2019-2030)
Figure 40. Mexico Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Immuno Oncology Assays Market Share by Country (2019-2030)
Figure 44. Turkey Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Immuno Oncology Assays Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Thermo Fischer Scientific Revenue Growth Rate in Immuno Oncology Assays Business (2019-2024)
Figure 47. Roche Diagnostics Revenue Growth Rate in Immuno Oncology Assays Business (2019-2024)
Figure 48. Agilent Technologies Revenue Growth Rate in Immuno Oncology Assays Business (2019-2024)
Figure 49. Illumina Revenue Growth Rate in Immuno Oncology Assays Business (2019-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock